February 20, 2019
This grant is part of the Translational Neural Devices program which provides support for translational activities and small clinical studies to advance the development of therapeutic or diagnostic devices that affect the nervous or neuromuscular systems.
“This grant represents the culmination of a great deal of scientific and engineering effort from undergraduates, graduate students, and faculty at UT Dallas. I'm thrilled to be able to transition this potentially transformative therapy to help stroke patients.” said Dr. Seth Hays, Director of Preclinical Research at the TxBDC.
NIH's TDR program aims to lead to an Investigation Device Exemption (IDE) from the U.S. Food and Drug Administration (FDA) to support a small clinical trial, or a Non-Significant Risk (NSR) designation from an Institutional Review Board (IRB). The program will also support a safety clinical trial to inform final device design.
*Research reported in this publication was supported by the National Institute Of Neurological Disorders And Stroke of the National Institutes of Health under Award Number UG3NS109497. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.